- Please check and comment entries here.
HNF1 homeobox A
1. Normal Function
The HNF1A gene provides instructions for making a protein called hepatocyte nuclear factor-1 alpha (HNF-1α). The HNF-1α protein acts as a transcription factor, which means it attaches (binds) to specific regions of DNA and helps control the activity of certain genes. While this protein is found in several tissues and organs, it seems to be especially important in the pancreas and liver.
Regulation of gene activity by the HNF-1α protein is critical for the growth and development of beta cells in the pancreas. Beta cells produce and release (secrete) the hormone insulin. Insulin helps regulate blood sugar levels by controlling how much sugar (in the form of glucose) is passed from the bloodstream into cells to be used as energy. The HNF-1α protein also controls genes involved in liver development. By controlling genes that regulate cell growth and survival, the HNF-1α protein is thought to act as a tumor suppressor, which means that it helps prevent cells from growing and dividing too rapidly or in an uncontrolled way.
The structure of HNF-1α includes several important regions that help it carry out its functions. One of the regions, called the dimerization domain, is critical for protein interactions. This region allows HNF-1α proteins to interact with each other or with other proteins that have a similar structure, creating a two-protein unit (dimer) that functions as a transcription factor. Another region, known as the DNA binding domain, binds to specific areas of DNA, allowing the dimer to control gene activity.
2. Health Conditions Related to Genetic Changes
2.1. Maturity-onset Diabetes of the Young
Mutations in the HNF1A gene cause maturity-onset diabetes of the young (MODY), which is a group of conditions characterized by abnormally high blood sugar levels. This form of diabetes usually begins before age 30. HNF1A gene mutations cause the most common type of MODY, called HNF1A-MODY (also known as MODY3). Early symptoms are caused by high blood sugar and include frequent urination (polyuria), excessive thirst (polydipsia), fatigue, blurred vision, weight loss, and recurrent skin infections. Over time, uncontrolled high blood sugar can lead to eye and kidney problems.
HNF1A gene mutations that cause HNF1A-MODY occur in one of the two copies of the gene in each cell. These mutations result in production of an altered HNF-1α protein that is unable to function normally. Some changes prevent the HNF-1α protein from forming dimers; others prevent the protein from entering the nucleus where it interacts with DNA; still others prevent the transcription factor from attaching to DNA to control gene activity. These changes interrupt transcription, altering gene activity in cells. As a result, beta cell development and function are impaired. The cells are less able than normal to produce insulin in response to sugar in the blood, which means blood sugar cannot be controlled. Elevated blood sugar results in the signs and symptoms of MODY.
Rarely, individuals with HNF1A-MODY develop one or more noncancerous (benign) liver tumors called hepatocellular adenomas. In these individuals, a mutation occurs in the second copy of the HNF1A gene in liver cells. This second mutation, called a somatic mutation, is not inherited. It is unclear how the mutations cause liver cells to grow uncontrollably and form tumors.
2.2. Other Disorders
Hepatocellular adenomas also occur in people without HNF1A-MODY (described above). In these individuals, the tumors are associated with somatic mutations in both copies of the HNF1A gene. While rare, hepatocellular adenomas occur in women more frequently than in men, and most affected individuals develop a single tumor. HNF1A-mutated hepatocellular adenomas (also known as H-HCA) account for about 30 to 40 percent of this type of liver tumor. The HNF1A gene mutations that cause these tumors severely reduce or eliminate the function of the HNF-1α protein in affected liver cells. It is unclear how loss of HNF-1α function causes cells to grow uncontrollably and form tumors.
3. Other Names for This Gene
HNF1 Homeobox A Gene
This entry is adapted from https://medlineplus.gov/genetics/gene/hnf1a
- Balamurugan K, Bjørkhaug L, Mahajan S, Kanthimathi S, Njølstad PR, Srinivasan N, Mohan V, Radha V. Structure-function studies of HNF1A (MODY3) gene mutationsin South Indian patients with monogenic diabetes. Clin Genet. 2016Dec;90(6):486-495. doi: 10.1111/cge.12757.
- Bluteau O, Jeannot E, Bioulac-Sage P, Marqués JM, Blanc JF, Bui H, BeaudoinJC, Franco D, Balabaud C, Laurent-Puig P, Zucman-Rossi J. Bi-allelic inactivationof TCF1 in hepatic adenomas. Nat Genet. 2002 Oct;32(2):312-5.
- Fu J, Wang T, Zhai X, Xiao X. Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature. Endocrine. 2020 Mar;67(3):544-551. doi: 10.1007/s12020-019-02138-x.
- Haliyur R, Tong X, Sanyoura M, Shrestha S, Lindner J, Saunders DC, AramandlaR, Poffenberger G, Redick SD, Bottino R, Prasad N, Levy SE, Blind RD, Harlan DM, Philipson LH, Stein RW, Brissova M, Powers AC. Human islets expressing HNF1Avariant have defective β cell transcriptional regulatory networks. J Clin Invest.2019 Jan 2;129(1):246-251. doi: 10.1172/JCI121994.
- Malikova J, Kaci A, Dusatkova P, Aukrust I, Torsvik J, Vesela K, Kankova PD,Njølstad PR, Pruhova S, Bjørkhaug L. Functional Analyses of HNF1A-MODY VariantsRefine the Interpretation of Identified Sequence Variants. J Clin EndocrinolMetab. 2020 Apr 1;105(4). pii: dgaa051. doi: 10.1210/clinem/dgaa051.
- Najmi LA, Aukrust I, Flannick J, Molnes J, Burtt N, Molven A, Groop L,Altshuler D, Johansson S, Bjørkhaug L, Njølstad PR. Functional Investigations of HNF1A Identify Rare Variants as Risk Factors for Type 2 Diabetes in the GeneralPopulation. Diabetes. 2017 Feb;66(2):335-346. doi: 10.2337/db16-0460.
- Yamagata K. Roles of HNF1α and HNF4α in pancreatic β-cells: lessons from amonogenic form of diabetes (MODY). Vitam Horm. 2014;95:407-23. doi:10.1016/B978-0-12-800174-5.00016-8. Review.